GPX4 and chronic obstructive pulmonary disease: We also found that higher serum levels of GPX4 were associated with higher FFMIs, and that patients with lower serum levels of GPX4 tend to walk less in the 6MWD test and have a higher risk of developing COPD exacerbations during the following 12 months.